Draft Greater Cambridge Local Plan for consultation

Comment

Representation ID: 209112

Received: 30/01/2026

Respondent: Wellcome Genome Campus Ltd

Agent: David Lock Associates

WGCL fully support the identification and recognition of the Southern Cluster along with the clear statement of intent with regard to the Campus. This strategy commitment is welcomed. The Plan recognises the potential for the evolved Campus to function as a place with homes, jobs and services, that might underpin classification in the settlement hierarchy in the future (as stated in Policy S/SH). The Campus will increasingly have the characteristics of a small town and WGCL are formulating a compelling Vision for this further evolution.

Comment

Representation ID: 209113

Received: 30/01/2026

Respondent: Wellcome Genome Campus Ltd

Agent: David Lock Associates

The policy for the campus should be clearer between the expansion land and the modernisation of the existing campus. The quatum and uses expressed are solely on the expansion land, and the policy should recognise the uses on the expansion land and separately the uses supported more generally. The policy wording should recognise the potential of the existing campus. The wording around the masterplan requirement should be clearer how it relates to the approved Strategic Design Guide.

Comment

Representation ID: 209114

Received: 30/01/2026

Respondent: Wellcome Genome Campus Ltd

Agent: David Lock Associates

We propose a flexible policy framework that defines clear boundaries for “Hinxton Campus” and “Hinxton Village”, encourages mixed‑use ground floors, phased redevelopment and aligns with national growth corridors.

Comment

Representation ID: 209115

Received: 30/01/2026

Respondent: Wellcome Genome Campus Ltd

Agent: David Lock Associates

We suggest land‑use and design guidance that sustains research, revitalises the conference centre, provides utilities, allows secondary uses, delivers 1 500 residential units for Campus workers (with scope for more) and protects heritage and biodiversity.

Comment

Representation ID: 211226

Received: 30/01/2026

Respondent: Wellcome Genome Campus Ltd

Agent: David Lock Associates

The scope of the sciences supported onsite is too narrow and needs to be reviewed.

Comment

Representation ID: 211227

Received: 30/01/2026

Respondent: Wellcome Genome Campus Ltd

Agent: David Lock Associates

The planning permission (S/439/18/OL) is for the expansion land only and it is worded in a way that is restrictive in places and does not reflect the planning permission’s wording. Specifically around campus housing, sales and letting system, temporary and meanwhile uses, public open space.

Comment

Representation ID: 211228

Received: 30/01/2026

Respondent: Wellcome Genome Campus Ltd

Agent: David Lock Associates

The policy and the vision should reflect the ambition and substantial scale of development now underway at the Wellcome Genome Campus. The focus is on a ‘one campus’ agenda. The plan needs to be permissive to growth and change and should be redrafted broadly to cover the vision, open connectivity, intensification, enrichment of science ecosystem, exceptional environment and experience, land use, spatial framework, built form, the setting and sustainability.

Comment

Representation ID: 211229

Received: 30/01/2026

Respondent: Wellcome Genome Campus Ltd

Agent: David Lock Associates

In parts, the evidence base remains a little behind the curve on the importance of the Campus within the Southern Cluster. For example, Figure 3.3 in the Infrastructure Delivery Plan, which identifies growth locations does not include Hinxton. WGCL has commissioned a science and technology advisory group, with an external chair and members, to work with it (and major occupiers at the Campus) on a forward-looking ‘Science Strategy’ which will be shared with stakeholders over the coming months and in advance of the Regulation 19 Consultation.